StockData
IRTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

iRhythm Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$109.60+0.94 (+0.87%)

Close on Oct 19, 2026

Market cap
$3.61B
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Oct 29, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 6, 2026After market close$224.20M$-0.01$0.58
Q1 FY2026
Ended Mar 31, 2026
Apr 30, 2026After market close$199.40M$-0.43$-0.35
Q4 FY2025
Ended Dec 31, 2025
Feb 19, 2026After market close$208.90M––
Q3 FY2025
Ended Sep 30, 2025
Oct 30, 2025After market close$192.90M$-0.16$-0.06
Q2 FY2025
Ended Jun 30, 2025
Jul 31, 2025After market close$186.70M$-0.44$-0.32
Q4 FY2024
Ended Dec 31, 2024
Feb 20, 2025After market close$164.30M$-0.04$0.01
Q3 FY2024
Ended Sep 30, 2024
Oct 30, 2024After market close$147.50M$-1.48$-1.26
Q2 FY2024
Ended Jun 30, 2024
Aug 1, 2024After market close$148.00M$-0.65$-0.61
Q1 FY2024
Ended Mar 31, 2024
May 2, 2024After market close$131.90M$-1.47$-1.23
Q4 FY2023
Ended Dec 31, 2023
Feb 22, 2024After market close$132.50M$-1.26$-0.84
Q3 FY2023
Ended Sep 30, 2023
Nov 2, 2023After market close$124.60M$-0.89$-0.79

Company guidance

Outlook given with results on Aug 6, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
adjusted EBITDA marginnon-GAAPfull year 202613% to 14%New
revenueGAAPfull year 2026$880.00M to $890.00MNew

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements iRhythm filed with the SEC